M&A Pfizer splits into three after failing to sell consumer unit Pfizer has decided to split into three after it failed to sell its consumer healthcare business a few months ago.
News Pfizer could fetch $15bn for consumer health business Pfizer is considering selling its consumer healthcare business in a deal that could be worth around $15 billion.
News Sanofi and BI finalise swap to create market leading consume... Sanofi and BI finalise CHC and animal health swap
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
